Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative bone scintigraphy. A methodological evaluation in prostate cancer.

A Rydh1, K R Ahlström, A Larsson

  • 1Department of Diagnostic Radiology, Umeå University Hospital, Sweden.

Acta Radiologica (Stockholm, Sweden : 1987)
|March 31, 2000
PubMed
Summary

Quantitative bone scintigraphy (QBS) offers a simple method to assess bone metastases in prostate cancer (PCa). Changes in QBS values correlated with prostate-specific antigen (PSA) levels, indicating treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term clinical outcome in patients with glutathione synthetase deficiency.

The Journal of pediatrics·2001
Same author

The pressure at the lower inflexion point has no relation to airway collapse in surfactant-treated premature lambs.

Acta anaesthesiologica Scandinavica·2001
Same author

Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.

Anticancer research·2001
Same author

Is it necessary to order aspartate aminotransferase with alanine aminotransferase in clinical practice?

Clinical chemistry·2001
Same author

Angiogenesis and angiogenic growth factors in Wilms tumor.

The Journal of urology·2001
Same author

An open and flexible framework for computer aided surgical training.

Studies in health technology and informatics·2001

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Medical Imaging

Background:

  • Bone scintigraphy (BS) is crucial for detecting skeletal involvement in prostate cancer (PCa).
  • Objective quantification of treatment response in skeletal metastases remains a challenge.
  • Prostate-specific antigen (PSA) is a key biomarker for monitoring PCa progression and treatment response.

Purpose of the Study:

  • To evaluate a straightforward method for quantifying focal activity in bone scintigraphy.
  • To assess the utility of quantitative bone scintigraphy (QBS) in monitoring therapeutic effects in prostate cancer skeletal metastases.

Main Methods:

  • Gamma camera calibration was performed using a phantom.
  • Quantitative bone scintigraphy (QBS) was conducted on 11 men with newly diagnosed PCa and skeletal involvement.

Related Experiment Videos

  • QBS was repeated after 4-8 months of endocrine therapy, and changes were compared with serum PSA levels.

    • Main Results:

    • A decrease in QBS values, indicating regression, was observed in 8 out of 11 patients responding to therapy (as indicated by PSA levels).
    • The overall mean error for QBS values was 15%.
    • QBS demonstrated a correlation between quantitative imaging findings and biochemical markers of treatment response.

    Conclusions:

    • This QBS method is a relatively simple procedure for evaluating therapeutic effects in skeletal metastases.
    • QBS may provide objective assessment of treatment response in prostate cancer patients with bone involvement.
    • Further validation in larger clinical studies is warranted to confirm the reliability and clinical utility of this QBS method.